Ewa Brzeziańska-Lasota

18PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsImmunogenetics (incl. genetic immunology)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.

|Jul 15, 2026
Lung Tissue Microbiome in NSCLC Patients: Metabarcoding Analysis Identifies Escherichia-Shigella as an Abundant Taxon.

|Jun 12, 2026
The Role of REL and IL2 and Their Polymorphisms in the Pathogenesis of Vitiligo-Exploratory Genetic Association Study.

|Aug 20, 2025
A preliminary bioinformatic screen to identify SRI SMC2 PSIP1 TLE4 and MSX1 as potential diagnostic and prognostic markers of osteoarthritis.

Jolanta Kryczka, Ewa Brzeziańska-Lasota, Michał Pikuła

|Feb 26, 2025
MMP13 mRNA Expression Level as a Potential Marker for Knee OA Progression-An Observational Study.

Kamila Baran, Aleksandra Czechowska, Karolina Kopacz

|Feb 26, 2025
The Expression Level of SOX Family Transcription Factors' mRNA as a Diagnostic Marker for Osteoarthritis.

Kamila Baran, Ewa Brzeziańska-Lasota, Jakub Kryczka

Pageof 3

Frequent Collaborators

8 joint publications

Monika Migdalska-Sęk

6 joint publications

Jakub Mateusz Kryczka

5 joint publications

Karolina H Czarnecka-Chrebelska

5 joint publications

Joanna Boncela